Results 101 to 110 of about 746,710 (176)

On-pump fibrillating heart mitral valve replacement with the SAPIEN™ XT transcatheter heart valve [PDF]

open access: yes, 2017
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter
Locca, Didier   +3 more
core  

New concepts in transcatheter mitral valve replacement

open access: yes, 2020
The most prevalent form of moderate to severe valve disease in developed countries is mitral regurgitation (MR), which affects ~10% of people older than 75 years of age. Roughly half of patients with severe symptomatic MR are not referred for surgery due
Goode, Dylan James Ellingham
core   +1 more source

On-pump fibrillating heart mitral valve replacement with the SAPIEN ™ XT transcatheter heart valve

open access: yes, 2013
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcifi-cation of the annulus.
Carlo Marcuccic   +7 more
core   +1 more source

What role for transcatheter mitral valve replacement?

open access: yes, 2019
Despite the safety and efficacy of transmitral valve repair techniques, transcatheter mitral valve replacement (TMVR) has emerged as a potential treatment option for patients with severe mitral regurgitation at high or prohibitive surgical risk. To date,
Tusa M   +5 more
core   +1 more source

A novel dual-orifice mitral bioprosthesis: Proof-of-concept in an ovine modelCentral MessagePerspective

open access: yesJTCVS Open
Objective: Conventional large mitral bioprostheses may cause left ventricular outflow tract obstruction. A dual-orifice mitral bioprosthesis was designed for both surgical and transcatheter valve replacement.
Jinmiao Chen, MD, PhD   +9 more
doaj   +1 more source

Transcatheter mitral valve repair with the PASCAL precision system: First case in Singapore

open access: yes
Severe mitral regurgitation (MR) is associated with significant mortality and morbidity when left untreated.1 In patients who are not suitable for surgery, transcatheter edge-to-edge repair (TEER) provides a minimally-invasive therapeutic option.
Khung Keong Yeo   +4 more
core   +1 more source

The use of transcatheter aortic valve replacement vs surgical aortic valve replacement for the treatment of aortic stenosis

open access: yes, 2015
Hanna A Jensen, Lillian L Tsai, Vinod H Thourani Division of Cardiothoracic Surgery, Joseph B Whitehead Department of Surgery, Structural Heart and Valve Center, Emory University School of Medicine, Atlanta, GA, USA Abstract: Severe aortic stenosis (AS)
Tsai LL, Jensen HA, Thourani VH
core  

Transcatheter Mitral Valve Replacement Using Annular Reduction by Cinching With TEER in the Commissure (ARCTIC).

open access: yes
Background: Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited.
Elison, David   +10 more
core   +1 more source

Transcatheter Mitral Valve Replacement Using a Dedicated Mitral Valve System. [PDF]

open access: yesJACC Case Rep
Echarte-Morales J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy